The E3 ubiquitin ligase SIAH2 is a prosurvival factor overexpressed in oral cancer

Anticancer Research

Volumn 33, Issue 11, 2013, Pages 4965-4974

  Hsieh, Shu Chen ^a   Kuo, Sheng Nan ^b   Zheng, Yi Han ^a   Tsai, Ming Hsui ^c,d   Lin, Yu Sheng ^d   Lin, Ju Hwa ^d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Oral cancer; Siah2; Ubiquitin ligase

Indexed keywords

PROTEIN P53; SIGNIFICANCE OF SEVEN IN ABSENTIA HOMOLOG 2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; ORAL CANCER; SIAH2; UBIQUITIN LIGASE;

ADULT; AGED; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM GRADING; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES;

EID: 84891362683     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Moore RJ, Doherty DA, Do KA, Chamberlain RM and Khuri FR: Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx. Ethnicity Health 6(3-4): 165-177, 2001.
2. Petersen PE: The World Oral Health Report 2003: Continuous improvement of oral health in the 21st century-the approach of the WHO Global Oral Health Programme. Commun Denti Oral Epidemiol 31(Suppl 1): 3-23, (2003)
3. Jeng JH, Chang MC and Hahn LJ: Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 37(6): 477-492, 2001.
4. O'Regan EM, Toner ME, Smyth PC, Finn SP, Timon C, Cahill S, Flavin R, O'Leary JJ and Sheils O: Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients. Head Neck 28(4): 330-338, 2006.
5. Uchida K, Oga A, Okafuji M, Mihara M, Kawauchi S, Furuya T, Chochi Y, Ueyama Y and Sasaki K: Molecular cytogenetic analysis of oral squamous cell carcinomas by comparative genomic hybridization, spectral karyotyping, and fluorescence in situ hybridization. Cancer Genet Cytogenet 167(2): 109-116, 2006.
6. Hoeller D and Dikic I: Targeting the ubiquitin system in cancer therapy. Nature 458(7237): 438-444, 2009.
7. Bedford L, Lowe J, Dick LR, Mayer RJ and Brownell JE: Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Revi Drug Discov 10(1): 29-46, 2011.
8. Carthew RW and Rubin GM: seven in absentia, a gene required for specification of R7 cell fate in the Drosophila eye. Cell 63(3): 561-577, 1990.
9. Habelhah H, Frew IJ, Laine A, Janes PW, Relaix F, Sassoon D, Bowtell DD and Ronai Z: Stress-induced decrease in TRAF2 stability is mediated by SIAH2. EMBO J 21(21): 5756-5765, 2002.
10. Firth JD: Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequence. J of Biol Chem 270(49): 29083-29089, 1995.
11. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P and Semenza GL: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63(5): 1138-1143, 2003.
12. Bruick RK: Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Acad Scie USA 97(16): 9082-9087, 2000.
13. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH and Harris AL: HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 61(18): 6669-66673, 2001.
14. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G and Semenza GL: Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 59(16): 3915-3918, 1999.
15. Kramer OH, Stauber RH, Bug G, Hartkamp J and Knauer SK: SIAH proteins: Critical roles in leukemogenesis. Leukemia 27(4): 792-802, 2013.
16. Sun S, Schiller JH and Gazdar AF: Lung cancer in never smokers - a different disease. Nat Rev Cancer 7(10): 778-790, 2007.
17. Sharma SV, Bell DW, Settleman J and Haber DA: Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7(3): 169-181, 2007.
18. Brambilla E, Travis WD, Colby TV, Corrin B and Shimosato Y: The new World Health Organization Classification of Lung Tumours. Eur Resp J 18(6): 1059-1068, 2001.
19. Schubbert S, Shannon K and Bollag G: Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7(4): 295-308, 2007.
20. Ko SY, Lin SC, Chang KW, Wong YK, Liu CJ, Chi CW and Liu TY: Increased expression of amyloid precursor protein in oral squamous cell carcinoma. Int J Cancer 111(5): 727-732, 2004.
21. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4): 402-408, 2001.
22. Lin JH, Hsieh SC, Chen JN, Tsai MH and Chang CC: WWP1 gene is a potential molecular target of human oral cancer. Oral Surg, Oral Medi, Oral Pathol Oral Radiol 116(2): 221-231, 2013.
23. Gyongyosi E, Szalmas A, Ferenczi A, Konya J, Gergely L and Veress G: Effects of human papillomavirus (HPV) type 16 oncoproteins on the expression of involucrin in human keratinocytes. Virol J 9: 36, 2012.
24. Frew IJ, Hammond VE, Dickins RA, Quinn JMW, Walkley CR, Sims NA, Schnall R, Della NG, Holloway AJ, Digby MR, Janes PW, Tarlinton DM, Purton LE, Gillespie MT and Bowtell DDL: Generation and analysis of Siah2 -mutant mice. Mol Cell Bio 23(24): 9150-9161, 2003.
25. Confalonieri S, Quarto M, Goisis G, Nuciforo P, Donzelli M, Jodice G, Pelosi G, Viale G, Pece S and Di Fiore PP: Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor. Oncogene 28(33): 2959-2968, 2009.
26. Jansen MP, Ruigrok-Ritstier K, Dorssers LC, van Staveren IL, Look MP, Meijer-van Gelder ME, Sieuwerts AM, Helleman J, Sleijfer S, Klijn JG, Foekens JA and Berns EM: Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer. Breast Cancer Research and Treat 116(2): 263-271, 2009.
27. Moller A, House CM, Wong CS, Scanlon DB, Liu MC, Ronai Z and Bowtell DD: Inhibition of Siah ubiquitin ligase function. Oncogene 28(2): 289-296, 2009.
28. Chan P, Moller A, Liu MC, Sceneay JE, Wong CS, Waddell N, Huang KT, Dobrovic A, Millar EK, O'Toole SA, McNeil CM, Sutherland RL, Bowtell DD and Fox SB: The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression. Breast Cancer Res 13(1): R19, 2011.
29. House CM, Moller A and Bowtell DD: Siah proteins: Novel drug targets in the Ras and hypoxia pathways. Cancer Res 69(23): 8835-8838, 2009.
30. Ahmed AU, Schmidt RL, Park CH, Reed NR, Hesse SE, Thomas CF, Molina JR, Deschamps C, Yang P, Aubry MC and Tang AH: Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth. J Natl Cancer Inst 100(22): 1606-1629, 2008.
31. Qi J, Pellecchia M and Ronai ZA: The Siah2-HIF-FoxA2 axis in prostate cancer - new markers and therapeutic opportunities. Oncotarget 1(5): 379-385, 2010.
32. Nakayama K, Frew IJ, Hagensen M, Skals M, Habelhah H, Bhoumik A, Kadoya T, Erdjument-Bromage H, Tempst P, Frappell PB, Bowtell DD and Ronai Z: Siah2 regulates stability of prolyl-hydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia. Cell 117(7): 941-952, 2004.
33. Mohamed KM, Le A, Duong H, Wu Y, Zhang Q and Messadi DV: Correlation between VEGF and HIF-1 α expression in human oral squamous cell carcinoma. Exp Mol Pathol 76(2): 143-152, 2004.
34. Uehara M, Sano K, Ikeda H, Nonaka M and Asahina I: Hypoxia-inducible factor 1 alpha in oral squamous cell carcinoma and its relation to prognosis. Oral Oncol 45(3): 241-246, 2009.